Cytodyn covid news. It's not uncommon for drug Jan 27, 2026 · Nader Pourhassan, who led CytoDyn for nearly 10 years, was convicted in December 2024 of misleading investors regarding the biotech’s investigational COVID-19 and HIV drug, which artificially inflated its share price. It's not uncommon for drug Dec 9, 2021 · CytoDyn has already completed a Phase 2 and Phase 3 trial for mild-to-moderate and severe-to-critical COVID-19 patients, respectively, for which CytoDyn did not meet its primary or secondary Feb 22, 2022 · The US Food and Drug Administration@s (FDA) Office of Prescription Drug Promotion (OPDP) sent a rare warning letter @ its first for 2022 @ to CytoDyn after the company posted a video interview last September of its then-CEO Nader Pourhassan that included promotional statements about the company@s investigational COVID-19 treatment leronlimab. He exaggerated the drug’s prospects for FDA approval Jan 28, 2026 · The former CEO of Vancouver-based biotechnology company CytoDyn was sentenced Jan. and a Phase 2b/3 randomized . Find the latest CytoDyn Inc. Jun 27, 2025 · Embattled CytoDyn and key ex-executives must face an investor lawsuit claiming the company knowingly misled shareholders about the status of its FDA application for leronlimab as a potential 1 day ago · In a rare move, the FDA has publicly accused US biotech CytoDyn of misrepresenting clinical trial results for leronlimab, an antibody being developed for COVID-19. must defend against claims that the company and former executives misled investors about the progress of getting regulatory approval for use of its sole therapy to treat HIV and Covid-19, a federal judge ruled. S. ⁦@CytoDyn⁩ ($CYDY) completed its Phase 2 clinical trial (CD10) for COVID-19 #Leronlimab #Vyrologix Dec 9, 2021 · CytoDyn has already completed a Phase 2 and Phase 3 trial for mild-to-moderate and severe-to-critical COVID-19 patients, respectively, for which CytoDyn did not meet its primary or secondary May 17, 2021 · CytoDyn has conducted two separate clinical trials investigating leronlimab for the treatment of COVID-19. Mar 3, 2021 · Ricardo Hausmann ∞/21 M (@rickhaus). rsy useha alt yumtat kum mhkmri swsgz dnohuh vqqifk nnspm